Saama Technologies, Inc. (“Saama”), a leading clinical data analytics
company, issued a call-to-action on Clinical
Trials Day urging the analytics industry to commit to timely
deployment of solutions for biopharmaceutical companies and the
elimination of launch delays that too often hinder clinical operations.
Saama launched its new Product Guarantee as the vanguard of this
challenge, pledging to its biopharmaceutical partners a 4-week timeline
for activation and access to the out-of-the-box capabilities of its
award-winning Life
Science Analytics Cloud (LSAC).
“Time and again, Saama has heard our life science clients express
frustration regarding promises made by technology vendors about
timelines that were never met, leading to unsuccessful launches that
delayed clinical progress,” said Joe Ehrline, Vice President of Sales at
Saama Technologies. “Data analytics should facilitate, not hamper,
clinical development. Saama’s Product Guarantee will establish an
industry standard for delivering actionable business insights in a
defined period of time that will help move the clinical development
needle forward, while minimizing risk.”
“The life science industry has historically struggled with and been very
dissatisfied by the discrepancy between the promise of data analytics
activation timelines and the reality of inevitable, associated delays,”
said Alan S. Louie, Ph.D., Research Director, Life Sciences, IDC. “We
welcome Saama’s Product Guarantee, and hope that the company’s
call-to-action reverses this trend and leads to similar commitments from
other data analytics providers.”
Saama’s Product Guarantee is facilitated by the easy-to-use LSAC
platform, an AI-powered platform disrupting the planning, designing and
conduct of clinical trials across various stages of clinical
development. The platform’s flexibility drives its speed of deployment
and makes it easy to configure. LSAC seamlessly ingests, integrates,
curates, and harmonizes clinical trial operational and patient data from
proprietary and external data sources to deliver actionable,
regulatory-ready insights. LSAC’s novel deep learning approach
significantly compresses clinical program timelines from clinical plan
development to submission judgment for a New Drug Application (NDA).
For further details about the Saama Product Guarantee, contact: product-guarantee@saama.com.
About Clinical Trials Day
The Association
of Clinical Research Professionals (ACRP) has designated Monday, May
20, 2019 as Clinical Trials Day. Clinical Trials Day is a well-deserved
‘time out’ to recognize the people who conduct clinical trials and to
say “thanks” for what they do every day to improve public health. This
day of celebration also provides the ACRP community with a unique
opportunity to raise awareness of clinical trials – and of clinical
research as a career option – among the greater public.
About Saama Technologies, Inc.
Saama Technologies is the advanced clinical data and analytics company,
unleashing wisdom from data to deliver better actionable business
outcomes for the life sciences industry. Saama’s unified, AI-driven
clinical data analytics cloud platform seamlessly integrates, curates,
and animates unlimited sources of structured, unstructured, and
real-world data to deliver actionable insights across all therapeutic
areas. The award-winning platform gives unprecedented real-time
visibility into clinical data, enabling sponsors to file New Drug
Applications (NDAs) more efficiently to bring drugs to market faster and
at lower costs. For more information, visit http://www.saama.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190520005069/en/